AI assistant
Sending…
GENTEX CORP — Director's Dealing 2023
Mar 7, 2023
30893_dirs_2023-03-07_cafd1c06-b894-4120-b1f6-38ca35453585.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2023-03-06
Reporting Person: Boehm Neil (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-06 | Common Stock | M | 1242.00 | $15.69 | Acquired | 37418.00 | Direct |
| 2023-03-06 | Common Stock | S | 1242.00 | $28.41 | Disposed | 36176.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-03-06 | Employee Stock Option (Right to buy) | $15.69 | M | 1242.00 | Disposed | 2023-03-31 | Common Stock (1242.00) | Direct |
Footnotes
F1: These shares become exercisable as to 25% one year after date of grant and an additional 25% at each ensuing anniversary date.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19